Publications by authors named "K S Flatten"

Claim this Profile
C
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance.
Cordelia D McGehee, X Wei Meng, Xinyan Wu, Cristina Correia, Annapoorna Venkatachalam, Karen S Flatten

Nucleic Acids Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.
Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, Annapoorna Venkatachalam, Annabella R Strathman

NPJ Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors.
Annapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, Xianon Hou, Paula A Schneider, Karen S Flatten

Mol Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin, Karen S Flatten

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.
Jia Jia, Wenbo Ji, Antoine N Saliba, Clifford M Csizmar, Kaiqin Ye, Karen S Flatten

Cell Death Differ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis